- Aug 3/21
[University Health Network] researchers discover key stem cell dormancy mechanism that could help unlock future cancer treatments - Aug 3/21
New “universal switch” lets scientists fine-tune gene therapy - Aug 3/21
Clinics turning to potentially dangerous intranasal stem cell delivery - Aug 3/21
Novartis set to launch Zolgensma trial to expand use - Aug 2/21
New study could help develop novel treatments for neurodegenerative diseases - Aug 2/21
New cell therapy shows potential against solid tumours with KRAS mutations - Aug 2/21
Researchers find regenerating the inner ear may be possible - Jul 31/21
Science Saturday: Regenerative pipeline for spinal cord repair - Jul 31/21
A genetic shield: new technique protects optic nerve cells - Jul 30/21
“Greening” biomaterials and scaffolds used in regenerative medicine - Jul 29/21
Veteran biotech executive to run new [Harvard] centre aimed at boosting cell and gene therapies - Jul 29/21
Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance - Jul 29/21
Innovative gene therapy program paves the way for new treatments for neurodegenerative diseases - Jul 28/21
The Government of Canada announces biomanufacturing and life sciences strategy - Jul 28/21
Scalable automation is breaking the bottleneck on cell therapy manufacturing - Jul 28/21
Microbiome medicines could power up CAR-T cell therapies - Jul 27/21
Umbilical cord-derived mesenchymal stem cells show promise to treat muscular dystrophies - Jul 27/21
The talking man: new advances in regenerative medicine - Jul 27/21
Fact-checking stem cell therapy for autism: still a risky idea - Jul 27/21
FDA gives green light for multiple sclerosis stem cell trial - Jul 27/21
Study proposes methods to purge unstable regulatory T cells - Jul 26/21
New study provides clues to decades-old cell movement mystery - Jul 23/21
“Noisy” gene expression may help improve stem cell therapies - Jul 23/21
New understanding of cell stability with potential to improve immune cell therapies - Jul 23/21
Slow going with CAR T-cell therapy for solid tumours - Jul 23/21
Will good times roll soon for regenerative medicine? - Jul 22/21
Gene therapy for Fabry: early stages, promising results - Jul 22/21
New study provides clues to decades-old mystery about wound healing - Jul 22/21
New gene therapy approach shows signs of preventing vision loss from glaucoma - Jul 21/21
Treatment with endothelial cells reverses emphysema in model - Jul 21/21
Alberta to start screening newborns for spinal muscular atrophy through pilot project - Jul 20/21
Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy - Jul 20/21
Cellular programming spurs next-generation cell therapies - Jul 20/21
[The FDA’s] CBER targets four stem cell firms with untitled letters - Jul 20/21
New research moves novel gene therapy for heart failure closer to the clinic - Jul 19/21
First patient dosed in optogenetic gene therapy trial - Jul 19/21
Lonza, CN Bio partner on prevalidated hepatocytes for organ-on-a-chip range - Jul 19/21
Personalized immunotherapy response studied in body-on-a-chip cancer models - Jul 17/21
How designer DNA is changing medicine - Jul 16/21
Why companies should aim to generate value from their patents, not just protection - Jul 16/21
Envisioning a CRISPR/Cas9-based therapy for retinitis pigmentosa - Jul 15/21
Researchers partner with industry to create better gene therapy tools - Jul 15/21
National [U.S.] survey IDs gaps and opportunities for regenerative medicine workforce - Jul 14/21
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site - Jul 14/21
Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too - Jul 13/21
ExCellThera and Astellas enter into license for the use of molecule UM171 in the field of pluripotent stem cells - Jul 13/21
The dawn of a new era of regenerative medicine: tissue engineering comes of age - Jul 13/21
Stem cell Alzheimer’s disease research - Jul 13/21
How engineered RNA binding protein delivered in vivo by gene therapy could treat myotonic dystrophy - Jul 12/21
Equity and access need to be at the forefront of innovation in human genome editing
